Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Isotretinoin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,952Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of April 17, 2024
    Enforcement Report - Week of April 17, 2024

    17 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf

    FDA
    17 Apr 2024
    Share Share
    Upsher Smith Lab's Generic Isotretinoin Receives Approval In US
    Upsher Smith Lab's Generic Isotretinoin Receives Approval In US

    21 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212333

    FDA
    21 Sep 2021
    Share Share
    Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b of TMB-001
    Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b of TMB-001

    24 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/24/2285477/0/en/Timber-Pharmaceuticals-Announces-Last-Patient-Last-Visit-in-Phase-2b-CONTROL-Study-Evaluating-TMB-001-in-Moderate-to-Severe-Congenital-Ichthyosis.html

    GLOBENEWSWIRE
    24 Aug 2021
    Share Share
    Isotretinoin Capsules, a Generic Version of Absorica, Now Available
    Isotretinoin Capsules, a Generic Version of Absorica, Now Available

    29 Apr 2021

    // Diana Ernst, RPh EMPR

    https://www.empr.com/home/news/generics-news/isotretinoin-capsules-a-generic-version-of-absorica-now-available/

    Diana Ernst, RPh EMPR
    29 Apr 2021
    Share Share
    Upsher-Smith Lab Generic Isotretinoin Receives Approval In US
    Upsher-Smith Lab Generic Isotretinoin Receives Approval In US

    16 Apr 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213571

    FDA
    16 Apr 2021
    Share Share
    Timber Announces All CONTROL Study Sites Open and Enrolling Patients
    Timber Announces All CONTROL Study Sites Open and Enrolling Patients

    01 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/01/2056190/0/en/Timber-Pharmaceuticals-Announces-All-CONTROL-Study-Sites-Open-and-Enrolling-Patients-with-Moderate-to-Severe-Congenital-Ichthyosis.html

    GLOBENEWSWIRE
    01 Jul 2020
    Share Share